133 related articles for article (PubMed ID: 2167684)
1. Interaction of the dihydropyridine calcium antagonist, CD-349, with calmodulin.
Tanaka M; Muramatsu M; Aihara H; Otomo S
Biochem Pharmacol; 1990 Sep; 40(5):991-6. PubMed ID: 2167684
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of calmodulin function by CV-159, a novel dihydropyridine compound.
Umekawa H; Yamakawa K; Nunoki K; Taira N; Tanaka T; Hidaka H
Biochem Pharmacol; 1988 Sep; 37(18):3377-81. PubMed ID: 2844186
[TBL] [Abstract][Full Text] [Related]
3. Different sensitivities of Ca2+, calmodulin-dependent cyclic nucleotide phosphodiesterases from rabbit aorta and brain to dihydropyridine calcium channel blockers.
Matsushima S; Tanaka T; Saitoh M; Watanabe M; Hidaka H
Biochem Biophys Res Commun; 1987 Nov; 148(3):1468-74. PubMed ID: 2825687
[TBL] [Abstract][Full Text] [Related]
4. Alteration of cyclic GMP metabolism by CD-349, a novel calcium antagonist, and by sodium nitroprusside in bovine intrapulmonary artery and vein.
Tanaka M; Muramatsu M; Aihara H
Biochem Pharmacol; 1989 Jun; 38(12):1985-91. PubMed ID: 2545208
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of adenosine 3',5'-cyclic monophosphate phosphodiesterase by CD-349, a novel 1,4-dihydropyridine derivative: effect of EGTA on the inhibitory activity.
Tanaka M; Muramatsu M; Aihara H
Jpn J Pharmacol; 1987 Oct; 45(2):203-10. PubMed ID: 2830423
[TBL] [Abstract][Full Text] [Related]
6. Ca2+-dependent cyclic nucleotide phosphodiesterase is activated by poly(L-aspartic acid).
Tanaka T; Ito M; Ohmura T; Hidaka H
Biochemistry; 1985 Sep; 24(19):5281-4. PubMed ID: 3000429
[TBL] [Abstract][Full Text] [Related]
7. [Interaction of calcium agonists and antagonists with Ca-binding proteins and their effect on cyclic nucleotide phosphodiesterase].
Feoktistov IA; Baldenkov GN; Barannik IV; Cherviakov EB; Larionov NP
Biokhimiia; 1990 Apr; 55(4):754-9. PubMed ID: 2165822
[TBL] [Abstract][Full Text] [Related]
8. Direct interaction of calmodulin antagonists with Ca2+/calmodulin-dependent cyclic nucleotide phosphodiesterase.
Itoh H; Hidaka H
J Biochem; 1984 Dec; 96(6):1721-6. PubMed ID: 6099352
[TBL] [Abstract][Full Text] [Related]
9. Calmodulin antagonists enhance calcium binding to calmodulin.
Inagaki M; Tanaka T; Hidaka H
Pharmacology; 1983; 27(3):125-9. PubMed ID: 6622516
[TBL] [Abstract][Full Text] [Related]
10. KS-505a, an isoform-selective inhibitor of calmodulin-dependent cyclic nucleotide phosphodiesterase.
Ichimura M; Eiki R; Osawa K; Nakanishi S; Kase H
Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):311-6. PubMed ID: 8645223
[TBL] [Abstract][Full Text] [Related]
11. Increased cyclic nucleotide phosphodiesterase (PDE) and calmodulin activities in soluble fraction of Graves' thyroid: analysis of increase in Ca+2 dependence of PDE activities.
Yagura T; Nagata I; Kuma K; Uchino H
J Clin Endocrinol Metab; 1985 Jun; 60(6):1180-6. PubMed ID: 2987288
[TBL] [Abstract][Full Text] [Related]
12. Cytosolic and membrane-bound cyclic nucleotide phosphodiesterases from guinea pig cardiac ventricles.
Muller B; Stoclet JC; Lugnier C
Eur J Pharmacol; 1992 Mar; 225(3):263-72. PubMed ID: 1325367
[TBL] [Abstract][Full Text] [Related]
13. Effects of ruthenium red on activation of Ca2(+)-dependent cyclic nucleotide phosphodiesterase.
Masuoka H; Ito M; Nakano T; Naka M; Tanaka T
Biochem Biophys Res Commun; 1990 May; 169(1):315-22. PubMed ID: 1693502
[TBL] [Abstract][Full Text] [Related]
14. Slow calcium channel blockers and calmodulin. Effect of felodipine, nifedipine, prenylamine and bepridil on cardiac sarcolemmal calcium pumping ATPase.
Lamers JM; Cysouw KJ; Verdouw PD
Biochem Pharmacol; 1985 Nov; 34(21):3837-43. PubMed ID: 2933041
[TBL] [Abstract][Full Text] [Related]
15. A new Ca-antagonist, CD-349, binding to the Ca-channel of rat myocardium and brain and hog coronary artery.
Muramatsu M; Fujita-Tominaga A; Tanaka M; Ishii Y; Aihara H
Jpn J Pharmacol; 1988 Dec; 48(4):453-62. PubMed ID: 2854176
[TBL] [Abstract][Full Text] [Related]
16. Hydrophobic interaction of the Ca2+-calmodulin complex with calmodulin antagonists. Naphthalenesulfonamide derivatives.
Tanaka T; Ohmura T; Hidaka H
Mol Pharmacol; 1982 Sep; 22(2):403-7. PubMed ID: 7144734
[TBL] [Abstract][Full Text] [Related]
17. Modulation of calmodulin function and of Ca2+-induced smooth muscle contraction by the calmodulin antagonist, HT-74.
Tanaka T; Umekawa H; Saitoh M; Ishikawa T; Shin T; Ito M; Itoh H; Kawamatsu Y; Sugihara H; Hidaka H
Mol Pharmacol; 1986 Mar; 29(3):264-9. PubMed ID: 3005834
[TBL] [Abstract][Full Text] [Related]
18. Preparation of an enzymatically active cross-linked complex between brain cyclic nucleotide phosphodiesterase and 3-(2-pyridyldithio)propionyl-substituted calmodulin.
Kincaid RL
Biochemistry; 1984 Mar; 23(6):1143-7. PubMed ID: 6324862
[TBL] [Abstract][Full Text] [Related]
19. Purification and characterization of bovine lung calmodulin-dependent cyclic nucleotide phosphodiesterase. An enzyme containing calmodulin as a subunit.
Sharma RK; Wang JH
J Biol Chem; 1986 Oct; 261(30):14160-6. PubMed ID: 3021730
[TBL] [Abstract][Full Text] [Related]
20. The binding of the calcium channel blocker, bepridil, to calmodulin.
Itoh H; Tanaka T; Mitani Y; Hidaka H
Biochem Pharmacol; 1986 Jan; 35(2):217-20. PubMed ID: 3484629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
